Company: CRL
Filing Date: 2025-08-06
Form Type: 10-Q
Source: 0001100682-25-000034
Chunk: 36

Company: CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Filing Date: 2025-08-06
Form: 10-Q
Item: Item 2
Chunk 36
---
 revenue and identification services revenue and the effect of changes in foreign currency exchange rate; partially offset by decreased revenue in our Biologics Solutions business, driven by decreased demand for CDMO and Biologics Testing services.

Manufacturing operating income decreased $67.5 million compared to the corresponding period in 2024. Manufacturing operating income as a percentage of revenue for the six months ended June 28, 2025 was 0.9%, a decrease of 1790 bps from 18.8% for the corresponding period in 2024. Operating income and operating income as a percentage of revenue decreased primarily due to accelerated amortization expense as a result of a decrease in the remaining useful life of certain client relationships due to a loss of key customers within the CDMO business and restructuring activities, including asset impairments and site consolidation charges, compared to the corresponding period in 2024; partially offset by the higher revenue described above.

Unallocated Corporate

Six Months EndedJune 28, 2025June 29, 2024$ change% changeImpact of FX(in thousands, except percentages)Unallocated corporate$124,762 $119,594 $5,168 4.3 %0.1 %Unallocated corporate % of revenue6.2 %5.9 %30 bps

Unallocated corporate costs consist of selling, general and administrative expenses that are not directly related or allocated to the reportable segments. The increase in unallocated corporate costs of $5.2 million, or 4.3%, compared to the corresponding 

33 

CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

period in 2024 is primarily due to higher third-party legal and advisory costs incurred in connection with execution of the Cooperation Agreement. Costs as a percentage of revenue for the six months ended June 28, 2025 were 6.2%, an increase of 30 bps from 5.9% for the corresponding period in 2024.

Other Income (Expense) 

Six Months EndedJune 28, 2025June 29, 2024$ change% change(in thousands, except percentages)Other income (expense):Interest income$2,501 $5,212 $(2,711)(52.0)%Interest expense(57,851)(67,770)9,919 (14.6)%Other income (expense), net(12,057)3,593 (15